28th Feb 2012 17:30
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
The interest of David Brennan, a Director of the Company, in AstraZeneca PLC Ordinary Shares of $0.25 each, has changed as detailed below.
On 27 February 2012, Mr Brennan received shares from the vesting of a previously announced award made in February 2009 under the AstraZeneca Deferred Bonus Plan whereby he has now become beneficially entitled to the shares. Sufficient shares were withheld to cover certain tax obligations arising on the vesting.
Name of Director | Number of shares vested | Number of shares withheld | Net number of shares | Market price on vesting |
David R Brennan |
17,992 |
9,409 |
8,583 |
2856p |
Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share.
As a result of this transaction, Mr Brennan has an interest in 662,509 Ordinary Shares and 81,229 AstraZeneca ADSs, which together represent approximately 0.06% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
28 February 2012
Related Shares:
Astrazeneca